Prognostic significance of P53, Ki-67, EGFR, MDM2 and MGMT immunostaining in Brazilian series of low-grade astrocytoma who grade II, anaplastic astrocytoma grade III, and glioblastoma

被引：0
|
作者：
Andrade, C. V. [1 ,3 ]
Sao Martinho, A. L. [1 ]
Rodrigues, A. M. [1 ]
Fonseca, E. C. [1 ]
Silva, L. E.
Silvestre, P. A. F. [2 ]
Hahn, M. D. [1 ]
机构：
[1] UFF, Programa Posgrad Patol, Serv Patol HUAP, Rio De Janeiro, Brazil
[2] INCA, DIPAT, Rio De Janeiro, Brazil
[3] IFF FIOCRUZ, Dept Patol, Rio De Janeiro, Brazil
来源：
HISTOPATHOLOGY | 2010年 / 57卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
564
引用
收藏
页码：203 / 203
页数：1
相关论文
共 25 条
  • [1] Analysis of egfr gene amplification in Brazilian patients low-grade astrocytoma who grade II, anaplastic astrocytoma grade III, and glioblastoma
    Andrade, C. V.
    Sao Martinho, A. L.
    Rodrigues, A. M.
    Fonseca, E. C.
    Silva, L. E.
    Silvestre, P. A. F.
    Hahn, M. D.
    [J]. HISTOPATHOLOGY, 2010, 57 : 203 - 203
  • [2] Expression of Ki-67 and p53 as prognostic factors in low grade astrocytomas
    zapata, Marta
    Rivera-Luna, Roberto
    Bornstein, Leticia
    De Leon-Bojorge, Beatriz
    Garcia, Francisco
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 446 - 446
  • [3] ROLE OF P53 AS A PROGNOSTIC MARKER IN LOW-GRADE GLIOMA (WHO GRADE-II)
    BALTUCH, GH
    DETRIBOLET, N
    [J]. CRITICAL REVIEWS IN NEUROSURGERY, 1995, 5 (02) : 103 - 107
  • [4] Prognostic significance of MGMT methylation and expression of MGMT, P53, EGFR, MDM2 and PTEN in glioblastoma multiforme
    Limam, Sarra
    Missaoui, Nabiha
    Abdessayedl, Nihed
    Mestiri, Sarra
    Selmi, Boulbaba
    Mokni, Moncef
    Yacoubi, Mohamed Tahar
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 2019, 77 (03) : 307 - 317
  • [5] Correlation of molecular genetic analysis of p53, MDM2, P16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma
    Ushio, Y
    Tada, K
    Shiraishi, S
    Kamiryo, T
    Shinojima, N
    Kochi, M
    Saya, H
    [J]. FRONTIERS IN BIOSCIENCE, 2003, 8 : E281 - E288
  • [6] Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma
    Park, HR
    Jung, WW
    Bertoni, F
    Bacchini, P
    Park, JH
    Kim, YW
    Park, YK
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2004, 200 (06) : 439 - 445
  • [7] A clinicopathologic review of low-grade serous ovarian cancer: Clinical outcomes and patterns of p53 and Ki-67 immunohistochemistry staining
    Tenney, M.
    Tuller, E.
    Moore, K.
    Walker, J.
    Mannel, R.
    Landrum, L.
    Yang, J.
    Zuna, R.
    McMeekin, D.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S115 - S116
  • [8] Expression of p53, p21(WAF1/CIP1) and MDM2 in endometrial adenocarcinomas, and their correlation with Ki-67 and histologic grade.
    Afify, AM
    Werness, BA
    [J]. LABORATORY INVESTIGATION, 1997, 76 (01) : 551 - 551
  • [9] Combination of Ki-67, MCM2, p16, and p53 Expression Can Distinguish High Grade Serous Carcinoma From Low Grade Serous Tumors
    Kelting, Sarah M.
    Paquette, Cherie
    Smolkin, Mark E.
    Jazaeri, Amir A.
    Barrett, Megan R.
    Stoler, Mark H.
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 291A - 291A
  • [10] Combination of Ki-67, MCM2, p16, and p53 Expression Can Distinguish High Grade Serous Carcinoma From Low Grade Serous Tumors
    Kelting, Sarah M.
    Paquette, Cherie
    Smolkin, Mark E.
    Jazaeri, Amir A.
    Barrett, Megan R.
    Staler, Mark H.
    [J]. MODERN PATHOLOGY, 2016, 29 : 291A - 291A
123